热门资讯> 正文
里程碑制药公司GAAP每股收益为-0.14美元
2024-08-09 18:17
- Milestone Pharmaceuticals press release (NASDAQ:MIST): Q2 GAAP EPS of -$0.14.
- As of June 30, 2024, Milestone had cash, cash equivalents, and short-term investments of $83.3 million, compared to $66.0 million as of December 31, 2023.
More on Milestone Pharmaceuticals
- Seeking Alpha’s Quant Rating on Milestone Pharmaceuticals
- Historical earnings data for Milestone Pharmaceuticals
- Financial information for Milestone Pharmaceuticals
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
